Donanemab
Product Specifications
CAS Number
1931944-80-7
Target
Beta Amyloid|||Microtubule Associated
Related Pathways
Cytoskeletal Signaling|||Neuroscience
Purity
0.9919
Bioactivity
Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody that targets a pyroglutamate amyloid beta (A?) epitope at the N-terminus, showing potential for early Alzheimer's disease research [1] [2].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items